Received May 1, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | N/A | LT9HP | IM / RA |
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 946060 | IM / RA |
Patient reports significant limitation of abduction and her right arm since vaccine administration back in November. She received 2 in her right arm and one in her left arm. She reports some redness and swelling for lasting 1 week after vaccine administration. She denies any numbness or weakness or any radiating neuropathy. Describes localized pain in the anterior arm region in the distribution of the axillary nerve.
Swelling with previous vaccine, unknown which